Home Newsfeeds U.S. Considers Shooting Down Suspected Chinese Spy Balloon Over Atlantic

News

U.S. Considers Shooting Down Suspected Chinese Spy Balloon Over Atlantic

-Wall Street Journal

byCharles Gross

February 4, 2023

1 minute read

-Wall Street Journal

News

Hudbay Minerals Inc Announced Results of the Enhanced Pre-Feasibility Study (“PFS”) for Phase I of its 100%-owned Copper World Project in Arizona

By Benzinga Newsdesk

September 8, 6:07 AM

Hudbay Minerals Inc. ("Hudbay" or the "company") ((TSX, NYSE:HBM) today announced the results of the enhanced pre-feasibility study ("PFS") for Phase I of its 100%-owned Copper

HBM

These Analysts Revise Price Targets On Sportradar Following Q4 Results

By Lisa Levin

March 16, 8:49 AM

Sportradar Group AG (NASDAQ: SRAD) reported fourth-quarter results. Sportradar reported fourth-quarter revenue of €206.3 million ($220.7 million), up 35% year-over-year. The company reported an adjusted EBITDA loss of $37.6 million, which was improved on a year-over-year basis.

SRAD

Caribou Biosciences Presents Case Report On Long-Term Follow Up Of First Patient Dosed In Phase 1 ANTLER Trial At The Lymphoma, Leukemia, & Myeloma Congress 2022 October 18-22

By Benzinga Newsdesk

October 18, 9:01 AM

Caribou Biosciences, Inc. (NASDAQ:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the presentation of a case report for long-term follow up on the first patient

CRBU

JP Morgan Chase CEO Jamie Dimon Says We Lost A Bit Of Control On Inflation

By Michael Horton

February 23, 1:37 PM

-Reuters

JPM

U.S. Considers Shooting Down Suspected Chinese Spy Balloon Over Atlantic

Related Posts

Hudbay Minerals Inc Announced Results of the Enhanced Pre-Feasibility Study (“PFS”) for Phase I of its 100%-owned Copper World Project in Arizona

These Analysts Revise Price Targets On Sportradar Following Q4 Results

Caribou Biosciences Presents Case Report On Long-Term Follow Up Of First Patient Dosed In Phase 1 ANTLER Trial At The Lymphoma, Leukemia, & Myeloma Congress 2022 October 18-22

JP Morgan Chase CEO Jamie Dimon Says We Lost A Bit Of Control On Inflation